| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.092 | 0.07 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.056 | 0.2 |